Filing Details
- Accession Number:
- 0001053369-13-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-25 13:55:35
- Reporting Period:
- 2013-01-22
- Filing Date:
- 2013-01-25
- Accepted Time:
- 2013-01-25 13:55:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1053369 | Elite Pharmaceuticals Inc | ELTP | Pharmaceutical Preparations (2834) | 223542636 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1465825 | G Ashok Nigalaye | C/O Epic Pharma, Llc 227-15 North Conduit Avenue Laurelton NY 11413 | Chief Scientific Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-01-22 | 356,700 | $0.09 | 13,303,884 | No | 4 | S | Indirect | see footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | see footnote |
Footnotes
- Ashok G. Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer, and also serves as a director of the issuer.
- Of the 13,303,884 shares of common stock, 12,664,302 shares of common stock are owned indirectly through EI and 639,582 shares are owned directly by the reporting person.
Billionaire Hedge Funds
